Back to search

Article

Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer

2025-03-31

Abstract excerpt

<title>Abstract</title> <p>Background <italic>BRAF</italic> V600E mutation is a significant therapeutic target for thyroid cancer, including anaplastic thyroid cancer (ATC). Although targeted therapy for this mutation requires genomic testing in Japan, turnaround time (TAT) is often unacceptably long, especially for certain conditions, such as ATC, which is one of the most aggressive cancers. Here, we evaluated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c27fc2cc-22e0-5276-980f-041b6458db91
DOI
10.21203/rs.3.rs-5969512/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancerDOI 10.21203/rs.3.rs-5969512/v1
Histological and Immunohistochemical Braf V600e Mutation Detection in Papillary Thyroid CarcinomaSemantic proximity
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspirationSemantic proximity
High Concordance in Molecular Profiles Between Primary Tumors and Matched Lymph Node Metastases in Differentiated Thyroid Carcinoma: Implications for Clinical Sample SelectionSemantic proximity
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas.Semantic proximity
Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.Semantic proximity
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.Semantic proximity
BRAF V600E Gene Testing Combined with Serum TSH, TGAb, and TPOAb Testing for the Diagnosis of Malignancy in TI-RADS 4 NodulesSemantic proximity
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.Semantic proximity
Diagnostic value of thyroid imaging reporting and data system combined with BRAFV600E mutation analysis in Bethesda categories III-V thyroid nodules.Semantic proximity
An affordable immunohistochemical approach to estimate the prevalence of BRAFV600E in large cohort studies—establishing the baseline rate of BRAF mutation in an institutional series of papillary thyroid carcinoma from ThailandSemantic proximity
Comparative analysis of IHC, AMRS-PCR, and ddPCR for BRAF V600E mutation detection in papillary thyroid carcinoma.Semantic proximity
BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration.Semantic proximity
Select a neighboring publication to make it the new centre.